Syneos Health, Inc. (SYNH) Tops Q4 EPS by 14c, Offers Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q4 EPS of $0.70, $0.14 better than the analyst estimate of $0.56. Net revenue for the quarter came in at $750.5 million versus the consensus estimate of $760.38 million.

GUIDANCE:

Syneos Health, Inc. sees Q1 2018 EPS of $0.54-$0.60, versus the consensus of $0.60. Syneos Health, Inc. sees Q1 2018 revenue of $3.23-3.33 billion, versus the consensus of $3.21 billion.

Syneos Health, Inc. sees FY2018 EPS of $2.68-$2.94, versus the consensus of $2.57. Syneos Health, Inc. sees FY2018 revenue of $751-781 million, versus the consensus of $777.8 million.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• EQT Corp. (EQT) Tops Q1 EPS by 17c; offers outlook
• Visa (V) Tops Q2 EPS by 7c, offers guidance